Please assess the completion status of the following clinical trial:

Trial Title: Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Type 2 Diabetes Mellitus~* Postmenopausal female~* Age \>55 years~* Hemoglobin A1c between 7-10% within 6 months of the first visit.~Exclusion Criteria:~* Patients with type 1 Diabetes mellitus~* Patients with a history of GLP-1 receptor agonist/DPP4 inhibitor use~* eGFR \<30 ml/min in the last 3 months~* Patients with a history of pancreatitis~* Personal or family history of medullary thyroid cancer~* Patients with a history of treatment with anti-osteoporosis agents~* Documented secondary osteoporosis~* Documented presence of prosthesis or devices in the spine~* Unwilling or unable to consent

- Gender: FEMALE
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- GLP-1 cohort (Type: EXPERIMENTAL): Participants on GLP-1 receptor agonists
- Non GLP-1 cohort (Type: NO_INTERVENTION): Participants not on GLP-1 receptor agonists

Based on this trial design, predict the completion outcome and termination type (if applicable).